Tissue engineering follows the principles of cell and tissue culture, cloning and stem cell production, and materials science to develop biological substitutes, which could repair and maintain normal function. The biomaterials must be able to control the structure and function of engineered tissue by interacting with both transplanted and host cells. Either natural or synthetic biodegradable materials have been used as cell delivery scaffolds. The stem cell field is also advancing rapidly, opening new options for regenerative medicine. In the genitourinary system, tissue engineering has been applied experimentally for the reconstitution of pelvis, ureter, bladder, urethra, penile corpora cavernosa and testis. This literature review underlines recent advances that have occurred in tissue engineering and describes their clinical repercussions, particularly in offering novel therapies in urogenital pathology.
AtalaA.Tissue engineering for the replacement of organ function in the genitourinary system.Am J Transplant2004; 4: 58–73.
3.
AtalaA.Regenerative medicine in urology.BJU International2003; 92: 58–67.
4.
O’ ConnorR.C., HardingJ.N., SteinbergG.D.Novel modification of partial nephrectomy technique using porcine SIS.Urology2002; 60: 906–10.
5.
LiatsikosE.N., DinlecC.Z., KaporR. Ureteral reconstruction: SIS for the management of strictures and defects of the upper third of the ureter.J Urol2001; 165: 1719–25.
KnollL.D.Use of porcine SIS graft in the surgical management of Peyronie's disease.Urology2001; 57: 753–60.
10.
KroppB.P., ChengE.Y., PopeJ.C., BrockJ.W.The use of SIS for corporal body grafting in case of severe penile curvature.J Urol2002; 168: 1742–8.
11.
ParadisoM., SedighO., VolpeA. Un anno di esperienze con SIS-biomateriale nella chirurgia plastica peniena.Urologia2001; 68: 95–7.
12.
ProbstM., DahiyaR., CarrierS., TanaghoE.A.Reproduction of functional smooth muscle tissue and partial bladder replacement.Br J Urol1997; 79: 505–12.
13.
PechiotaH.J., DahmsS.E., NumesLS. in vitro functional properties of the rat bladder regenerated by the bladder acellular matrix graft.J Urol1998; 159: 1717–24.
ReddyP.P., BarrierasD.J., WilsonG. Regeneration of functional bladder substitutes using large segment acellular matrix allograft in a porcine model.J Urol2000; 164: 936–41.
16.
DucheneD.A., JacomidesL., OganK. Ureteral replacement using SIS and collagen inhibitor in a porcine model.J Endourol2004; 18: 507–11.
17.
PatersonR.F., LifstitsD.A., BeckSD. Multilayered SIS is inferior to analogous bowel for laparoscopic bladder augmentation.J Urol2002; 168: 2253–7.
18.
SoergelT.M., CainM.P., KaferM. Complications of SIS for corporal body grafting for proximal hypospadias.J Urol2003; 170: 1577–9.
19.
AtalaA.What's new in urology?Am Coll Surgeons2004; 199: 446–61.
20.
De FilippoR.E., YooJ.I., ChenF., AtalaA.Urethral replacement using cell-seeded tubularized collagen matrices.J Urol2002; 168: 1789–92.
21.
KershenR.T., YooJ.J., MorelandRB. Reconstitution of human corpus cavernosum smooth muscle in vitro and in vivo.Tiss Eng2002; 8: 529–38.
SoutgateJ., HuttonK.A., ThomasD.F., TrejdosiewiczL.K.Normal human urothelial cells in vitro: proliferation and induction of stratification.Laboratory invest1994; 71: 583–94.
24.
De AngeliS., Del PupL., PerazzettaE.Tissue engineering. per la ricostruzione di neo-vesciche: confronti tra modelli sperimentaliUrologia2002, 69: 407–18.
25.
De AngeliS., Del PupL., TonioloL. Sviluppo in vitro di neovesciche come modello sperimentale per la terapia endocavitaria dei tumori superficiali dell'urotelio.Urologia2002; 69: 103–6.
26.
De AngeliS., Del PupL., FandellaA. New experimental models for the in vitro reconstitution of human bladder mucosa.Int J Mol Med2004; 14: 367–72.
27.
KurzrockE.A., LieuD.K., DegraffenriedL.A., IsseroffR.R.Rat urothelium: improved techniques for serial cultivation, expansion, freezing and reconstitution onto acellular matrix.J Urol2005; 173. 281–5.
28.
SchultheissD., GabouevA.I., CebotariSBiological vascularized matrik for bladder tissue engineering: matrix preparation, reseeding technique and short-term implantation in a porcinemodel.J Urol2005; 173: 276–80.
29.
CampodonicoF., BenelliR., MichelazziA. Bladder cell culture on small intestinal submucosa as bioscaffold.Eur Urol2004; 46: 531–7.
30.
AtalaA., VacantiJ.P., PetersCA. Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffold in vivo.J Urol1992; 148: 658–65.
31.
OberpenningF.O., MengJ., YooJ., AtalaA.De novo reconstituition of a functional urinary bladder by tissue engineering.Nat Biotechnol1999; 17: 149–55.
32.
LanzaR.P., ChungH.Y., YooJJ. Generation of hystocompatible tissue using nuclear transplantation.Nat Biotechnol2002; 20: 689–96.
33.
ParienteJ.L., KimB.S., AtalaA.in vitro biocompatibility assessment of naturally-derived and syntetic biomaterials using normal human urothelial cells.J Biomed Mat Res2001; 55: 33–9.
34.
AtalaA.Bladder regeneration by tissue engineering. (reply to C.Alberti's letter) BJU International2002; 89: 972–3.
35.
AlbertiC., TizzaniA.Biomaterials in bladder replacement: our purposes and prospects.Urologia2002; 69: 269–9.
36.
AlbertiC.From the intestinal neobladder to the bioartificial bladder: remarks on some biological implications.Minerva Urol Nefrol2000; 52: 219–22.
37.
MilellaE.Brescia E, Massaro C et al. Physico-chemical properties of degradability of non-woven hyaluronan benzylic esters as tissue engineering scaffolds.Biomaterials2002; 23: 1053–63.
38.
FreedL.E., GrandeD.A., LingbinZ. Joint resurfacing using allograft chondrocytes and syntethic biodegradable polymer scaffolds.J Biomed Mater Res1994; 28: 891–9.
39.
GrigoloB., RosetiL., FioriniM. Transplantation of chondrocytes seeded on a hyluronan-derivative (Hyaff-11) into cartilage defects in rabbits.Biomaterials2001; 22: 2417–24.
40.
ChistoliniP., RuspantiniI., BiancoP. Biochemical evaluation of cell-loaded and cell free hydroxyapatite implants for reconstruction of segmental bone defects.J Mater Sci Med1999; 10: 739–42.
41.
ThomsonR.C., YaszemskiM.J., PowersJ.M., MicosA.G.Hydroxyapatite fiber reinforced poly (alfa-hydroxy ester) foams for bone regeneration.Biomaterials1998; 19: 1935–43.
42.
SheaL.D., WangD., FranceschiR.T., MooneyD.J.Engineered bone development from a pre-osteroblast cell line on 3D-scaffolds.Tissue eng, 2000; 6: 605–17.
43.
KoeglerW.S., GriffithL.G.Osteoblast response to PLGA tissue engineering scaffolds with modified surface chemistries.Biomaterials2004; 25: 2819–30.
44.
TsaiR.I., LiL.M., ChenJ.K.Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells.N Engl J Med2000; 343: 86–93.
45.
LiuH.C.Engineering endometrial tissue for developing artificial uterus.Comm International Biotechnology Conference, Taipei, 18 Dec 2001.
46.
McKieR.Men redundant? Now we don't need women either.The observer (UK)2002, 10 Feb.
47.
NiklansonL.E., LangerR.S.Advances in tissue engineering of blood vessels ad other tissues.Transpl Immunol1997; 5: 503–6.
WatanabeM., Shin'okaT., TohyamaS. Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model.Tissue Eng2001; 7: 429–39.
50.
TurnerN.J., KieltyC.M., WalkerM.G., CanfieldA.E.A novel hyaluronam-based biomaterial (Hyaff-ll) as a scaffold for endothelial cells in tissue engineered vascular grafts.Biomaterials2004; 25: 5955–64.
51.
LanzaR.P., LangerR., VacantiJ., Eds. Principles of tissue engineering.2nd Edition - San Diego, California, Academic Press2000.
52.
BurgK.J., HolderW.D.Jr., CulbersonCR. Comparative study of seeding methods for 3D-polymeric scaffold.J Biomat Mater Res2000; 51: 642–9.
53.
MooneyD.J., MikosA.G.Growing new organs.Sci Am1999; 280: 60–5.
54.
KaiharaS., KimS., KimBS. Survival and function of rat hepatocytes cocultured with nonparenchymal cells or sinusoidal endothelial cell on biodegradable polymers under flow conditions.J Pediatr Surg2000; 35: 1787–90.
55.
MuschlerG.F., NakamotoC., GriffithL.G.Engineering principles of clinical cell-based tissue engineering.J Bone Joint Surg Am2004; 86-A(7): 1541–58.
56.
AtalaA., SchlusselR.N., RetikA.B.Renal cell growth in vivo after attachment to biodegradable polymer scaffolds.J Urol1995; 153: 4–10.
57.
YooJ.J., AshkarS., AtalaA.Creation of functional kidney structures with excretion of urine-like fluid in vivo.Pediatrics1996; 98(Suppl): S605–11.
58.
SnyderE.Y., VescoviA.L.The possibility-perplexities of stem cells.Nat Biotechnol2000; 18: 827–8.
59.
PoulsonR., ForbesS.J., Hodivals-DilkeK. Bone marrow contributes to renal parenchymal turnover and regeneration.Pathol2001; 195: 229–35.
60.
KershenR.T., YooJ.J., MorelandRB. Reconstitution of human corpus cavernosum smooth muscle in vitro and in vivo.Tissue Eng2002; 8: 515–24.
61.
MageeT.R., FerriniM., GarbanHJ. Gene therapy of erectile dysfuncion in the rat with penile neuronal nitric oxide synthase.Biol Reprod2002; 67: 1003–41.
62.
SchultheissD.Regenerative medicine in andrology: tissue engineering and gene therapy.Eur Urol2004; 46: 162–9.
63.
SarazinP., RoyX., FavisE.D.Controlled preparation and properties of porous poly (L-lactide) obtained from a cocontinous blend of two biodegradable polymers.Biomaterials2004; 25: 5965–78.
64.
Mc GlohornJ.B., HolderW.D.Jr., GrimesLW. Evaluation of smooth muscle cell response using two type of porous polylactide scaffold with differing pore topography.Tissue Eng2004; 10: 505–14.
65.
SheridanM.H., SheaL.D., PetersM.C., MooneyD.J.Bioabsorbable polymer scaffolds for tissue engineering capable of substained growth factor delivery.J Control Release2000; 14: 91–102.
66.
HuangY.C., ConnelM., ParkY. Fabrication and in vitro testing of polymeric delivery system for condensed DNA.J Biomed Mater Res2003; 67A: 1384–92.
67.
WhittleseyK.J., SheaL.D.Delivery system for small molecule drugs, proteins, DNA; the neuroscience/biomaterials interface.Exp NeUrol2004; 190: 1–16.
68.
DerubeisA.R., CanceddaR.Bone marrow stromal cells in bone engineering: limitations and recent advances.Ann Biomed Eng2004; 32: 160–5.
69.
GiavarasiG., TschonM., DalyJH. Natural ad synthetic polyesters for musculoskeletal tissue repair.Int J Artif Organ2004; 27: 796–805.
AtalaA.Tissue engineering and regenerative medicine.Rejuven Res2004; 7: 15–31.
79.
AbuljadayelI.S.Induction of stem cell-like plasticity in mononuclear cells derived from unmobilised adult human peripheral blood.Curr Med Res Opin2004; 19: 355–75.
80.
SoriaJ.M., TaglialatelaP., Gil-PerotinS. Defective postnatal neurogenesis and disorganization of the rostral migratory stream in absence of the Vax-1 homeobox gene.J Neurosci2004; 24: 11171–81.
81.
AlbertiC., TizzaniA., PiovanoM., GrecoA.What's in pipeline about bladder reconstructive surgery?J Artif Organs2004; 27: 737–43.
82.
ZuccottiM., PonceR.H., BoianiM. The analysis of chromatin organisation allows selection of mouse antral oocytes competent for development to blastocyst.Zygote2002; 10: 73–8.
83.
LongoF., GaragnaS., MericoV. Nuclear localization of NORs and centromeres in mouse oocytes during folli-culogenesis.Mol Reprod Dev2003; 66: 279–90.
84.
GentileL., MontiM., SebastianoV. Single-cell quantitative RT-PCR analysis of Cpt1b and Cpt2b gene expression in mouse antral oocytes and in preimplantation embryos.Cytoget Genome Res2004; 105: 215–21.
85.
ShiehS.J., VacantiJ.P.State of the art tissue engineering; from tissue engineering to organ building.Surgery2005; 137: 1–7.
